blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2814490

EP2814490 - INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.08.2018
Database last updated on 26.07.2024
FormerThe patent has been granted
Status updated on  15.09.2017
FormerGrant of patent is intended
Status updated on  04.08.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
VIIV Healthcare UK (No.5) Limited
980 Great West Road
Brentford Middlesex TW8 9GS / GB
[2017/42]
Former [2016/43]For all designated states
VIIV Healthcare UK (No.5) Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS / GB
Former [2014/52]For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
Inventor(s)01 / WALKER, Michael, A.
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
02 / SORENSON, Margaret, E.
16 Collins Parkway
Meriden, CT 06450 / US
03 / NAIDU, B., Narasimhulu
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
04 / PEESE, Kevin
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
05 / JOHNSON, Barry, L.
21 Wooding Road
Wallingford, Connecticut 06492 / US
06 / PATEL, Manoj
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
 [2014/52]
Representative(s)Learoyd, Stephanie Anne, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2017/42]
Former [2014/52]Vögeli-Lange, Regina, et al
Swords Laboratories
Swiss Branch, Steinhausen
Hinterbergstrasse 16
6330 Cham / CH
Application number, filing date13705712.114.02.2013
[2017/42]
WO2013US26082
Priority number, dateUS201261599102P15.02.2012         Original published format: US 201261599102 P
US20131376658713.02.2013         Original published format: US201313766587
[2014/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013123148
Date:22.08.2013
Language:EN
[2013/34]
Type: A1 Application with search report 
No.:EP2814490
Date:24.12.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 22.08.2013 takes the place of the publication of the European patent application.
[2014/52]
Type: B1 Patent specification 
No.:EP2814490
Date:18.10.2017
Language:EN
[2017/42]
Search report(s)International search report - published on:EP22.08.2013
ClassificationIPC:A61K31/4375, C07D471/04, A61P31/18
[2014/52]
CPC:
C07D471/04 (EP,US); A61K31/4375 (EP,US); A61P31/18 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/52]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:HIV REPLIKATIONSINHIBITOREN FÜR MENSCHEN[2017/33]
English:INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION[2014/52]
French:INHIBITEURS DE RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE[2014/52]
Former [2014/52]HEMMER DER NEUBILDUNG MENSCHLICHER IMMUNDEFEKT-VIREN
Entry into regional phase01.09.2014National basic fee paid 
01.09.2014Designation fee(s) paid 
01.09.2014Examination fee paid 
Examination procedure01.09.2014Examination requested  [2014/52]
25.11.2014Amendment by applicant (claims and/or description)
04.08.2017Communication of intention to grant the patent
05.09.2017Fee for grant paid
05.09.2017Fee for publishing/printing paid
05.09.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.08.2017
Opposition(s)19.07.2018No opposition filed within time limit [2018/39]
Fees paidRenewal fee
11.02.2015Renewal fee patent year 03
10.02.2016Renewal fee patent year 04
07.02.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.02.2013
AL18.10.2017
AT18.10.2017
CY18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
MK18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
MT14.02.2018
IS18.02.2018
BE28.02.2018
[2020/34]
Former [2020/31]HU14.02.2013
AT18.10.2017
CY18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
MK18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
MT14.02.2018
IS18.02.2018
BE28.02.2018
Former [2020/28]HU14.02.2013
AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
MT14.02.2018
IS18.02.2018
BE28.02.2018
Former [2020/16]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
TR18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
MT14.02.2018
IS18.02.2018
BE28.02.2018
Former [2020/08]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
MT14.02.2018
IS18.02.2018
BE28.02.2018
Former [2019/12]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
IS18.02.2018
BE28.02.2018
Former [2019/09]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IE14.02.2018
LU14.02.2018
IS18.02.2018
Former [2018/52]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SI18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
LU14.02.2018
IS18.02.2018
Former [2018/44]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
MC18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/40]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
PL18.10.2017
RO18.10.2017
RS18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/37]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
PL18.10.2017
RS18.10.2017
SK18.10.2017
SM18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/35]AT18.10.2017
CZ18.10.2017
DK18.10.2017
EE18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
RS18.10.2017
SK18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/24]AT18.10.2017
FI18.10.2017
HR18.10.2017
LT18.10.2017
LV18.10.2017
RS18.10.2017
BG18.01.2018
NO18.01.2018
GR19.01.2018
IS18.02.2018
Former [2018/22]FI18.10.2017
LT18.10.2017
NO18.01.2018
Cited inInternational search[A]WO9915526  (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1-15* claims 1-10 *;
 [A]WO2009062289  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-15 * claims 1-50; table 1 *;
 [A]WO2009062308  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-15 * claims 1-30; tables 1,2 *
by applicantUS2007249583
 WO2007131350
 WO2009062285
 WO2009062288
 WO2009062289
 WO2009062308
    - PALELLA, F. J.; DELANY, K. M.; MOORMAN, A. C.; LOVELESS, M. 0.; FURHER, J.; SATTEN, G. A.; ASCHMAN, D. J.; HOLMBERG, S. D. N., ENGL. J. MED., (1998), vol. 338, pages 853 - 860
    - J. AM. CHEM. SOC., (2008), page 4253
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.